| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |